Mutation of the MXI1 gene in prostate cancer (original) (raw)

References

  1. Dalla-Favera, R., Martirotti, S., Galio, R.C., Erickson, J. & Croce, C.M. Translocation and rearrangement of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science. 219, 963–965 (1983).
    Article CAS Google Scholar
  2. Schwab, M. et al. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroWastoma. Proc. natn. Acad. Sci. U.S.A. 81, 4940–4944 (1984).
    Article CAS Google Scholar
  3. Nau, M. et al. L-myc, a new _myc_-related gene amplified and expressed in human small cell lung cancer. Nature. 318, 69–73 (1985).
    Article CAS Google Scholar
  4. Adams, J.M. et al. The c-myc oncogene driven by Immunoglobulin enhancer induces lymphoid malignancy in transgenlc mice. Nature 318, 533–538 (1985).
    Article CAS Google Scholar
  5. Murre, C., McCaw, P.S. & Baltimore, D. A new DMA binding and dimerizatlon motif in immunoglobulin, enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777–783 (1989).
    Article CAS Google Scholar
  6. Murrem, C. et al. Interactions between heterotogous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58, 537–544 (1989).
    Article Google Scholar
  7. Olson, E.N. MyoD family: a paradigm for development? Genes Dev. 4, 1454–1461 (1990).
    Article CAS Google Scholar
  8. Davis, R.L., Cheng, P.F., Lassar, A.B. & Weintraub, H., MyoD DNA binding domain contains a recognition code for muscle-specific gene expression. Cell 60, 733–746 (1990).
    Article CAS Google Scholar
  9. Lassar, A.B. et al. Functional activity of myogenic HLH protreins requires hetero-oligomerization with E12/E47-like proteins In vivo. Cell 66, 305–315 (1991).
    Article CAS Google Scholar
  10. Weintraub, H. et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251, 761–766 (1991).
    Article CAS Google Scholar
  11. Kato, G.J., Barrett, J., Villa-Garcia, M. & Dang, C. An amino terminal c-myc domain required for neoplastic transformation activates transcription. Molec. Cell. Biol. 10, 5914–6920 (1990).
    Article CAS Google Scholar
  12. Blackwood, E.M. & Eisenmann, R.N. Max: a helix-loop-helix-zipper protein that forms a sequence-specific DNA binding complex with myc. Science 251, 1211–1217 (1991).
    Article CAS Google Scholar
  13. Prendergast, G.C., Lawe, D. & Ziff, E.B. Association of myn, the murine homolog of max, with c-myc stimulates methylatton-sensitive DNA binding and ras cotransormation. Cell 66, 395–407 (1991).
    Article Google Scholar
  14. Ayer, D.E., Kretzner, L. & Elsenmann, R.N. Mad: a heteradimeric partner for Max that antagonizes myc transcriptlonal activity. Cell 72, 211–222 (1993).
    Article CAS Google Scholar
  15. Zervos, A., Gyuris, J. & Brent, R., Mxl1, a protein that specifically interacts with max to bind myc-max recognition sites. Cell 72, 223–232 (1993).
    Article CAS Google Scholar
  16. Smith, M.J., Charron-Prochownik, D.C. & Prochownik, E.V. The leucine zipper of c-myc is required for the full inhibition of erythroleukemia differentiation. Molec. Cell. Biol. 10, 5333–5339 (1990).
    Article CAS Google Scholar
  17. Dang, C.V. et al. Intracellular leucine zipper interactions suggest c-myc hetero-oligomerization. Molec. Cell. Biol. 11, 954–962 (1991).
    Article CAS Google Scholar
  18. Amati, B. et al. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interactions with Max. Nature 359, 423–426 (1992).
    Article CAS Google Scholar
  19. Kretzner, L., Blackwood, E.M. & Eisenman, R.N. Myc and Max proteins possess distinct transcriptional activities. Nature 359, 426–429 (1992).
    Article CAS Google Scholar
  20. Amati, B. et al. Oncogenic activity of the c-myc protein requires oligomerization with max. Cell 72, 233–245 (1993).
    Article CAS Google Scholar
  21. Amin, C., Wagner, A.J. & Hay, N. Sequence-specific transcriptional activation by Myc and repression by Max. Molec. Cell. Biol. 13, 383–390 (1993).
    Article CAS Google Scholar
  22. Gu, W., Chechova, K. & Dalla-Favera, R. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. natn. Acad. Sci. U.S.A. 90, 2935 (1993).
    Article CAS Google Scholar
  23. Lahoz, E.G., Xu, L., Schreiber, A. & DePinho, R. Suppression of Myc, but not Ela, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. natn. Acad. Sci. U.S.A. 91, 5503–5507 (1994).
    Article CAS Google Scholar
  24. Edelhoff, S. et al. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9, 665 (1994).
    CAS PubMed Google Scholar
  25. Shapiro, D.N. et al. Assignment of the human MAD and MXI1 genes to chromosomes 2p12–p13 and 10q24–q25. Genomics 23, 282–285 (1994).
    Article CAS Google Scholar
  26. Sreekantaiah, C., Baer, M.R., Sole, F., Preisier, H.F. & Sandberg, A.A. Translocation (2;7) (p13;q36) in a case of acute non-lymphocytic leukemia evolving from a myelodysplastic syndrome. Cancer Genet. Cytogenet. 35, 199–204 (1988).
    Article CAS Google Scholar
  27. Fleischman, E.W. et al. Chromsomal characteristics of malignant lymphoma. Hum. Genet. 82, 343–348 (1989).
    Article CAS Google Scholar
  28. Heisler, C.H., Phillip, P. & Hansen, M.M. B-cell chronic lymphocytic leukaemia: clonal chromosome abnormalities and prognosis In 89 cases. Eur. J. Haematol. 43, 397–403 (1990).
    Article Google Scholar
  29. Yoffe, G., Howard-eebles, P.N., Smith, G., Tucker, P.W., Buchanan, G.R. Childhood chronic lymphocytic leukemia with t (2;14) translocation. J. Pediatr. 116, 114–117 (1990).
    Article CAS Google Scholar
  30. Fults, D. & Pedone, C. Deletion mapping of the long arm of chromosome 10 In glioblastoma multiforme. Genes Chrom. Cancer. 7, 173–177 (1993).
    Article CAS Google Scholar
  31. Bird, M.L., Ueshima, Y., Rowley, J.D., Haren, J.M., Vardiman, J.W. Chromosome abnormalities In B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia 3, 182–191 (1989).
    CAS PubMed Google Scholar
  32. Atkin, N.B. & Baker, M.C. Chromosome study of five cancers in prostate. Hum. Genet. 70, 359–364 (1985).
    Article CAS Google Scholar
  33. Lundgren, R. et al. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chrom. Cancer. 4, 16–24 (1992).
    Article CAS Google Scholar
  34. Brothman, A.R., Peehl, D.M., Patel, A.M. & McNeal, J.E. Frequency and pattern of karyotypic abnormalities in human prostatic cancer. Cancer Res. 50, 3795–3803 (1990).
    CAS PubMed Google Scholar
  35. Arps, S. et al. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet. 66, 93–99 (1993).
    Article CAS Google Scholar
  36. Weinberg, R.A. Tumor suppressor genes. Science 254, 1138–1146 (1992).
    Article Google Scholar
  37. Levine, A.J. The tumor suppressor genes. Annu. Rev. Biochem. 62, 623–651 (1993).
    Article CAS Google Scholar
  38. Kalllo, O., Syrjanen, S., Tervahuauta, S. & Syrjanen, K. A simple method for isolation of DNA from formalin-fixed pafaffin-embedded samples for PCR. J. Virol. Meth. 35, 39–47 (1991).
    Article Google Scholar
  39. Padgett, R.A., Grabowski, P.J., Konaraka, M.M., Seiber, S. & Sharp, P.A. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55, 1119–1150 (1986).
    Article CAS Google Scholar
  40. Kazazian, H.H. & Boehm, C.D. Molecular basis and prenatal diagnosis of β-thalassemia. Blood. 72, 1107–1116 (1988).
    CAS PubMed Google Scholar
  41. Saiki, R.K. et al. Primer-directed enzymatic amplifications of DNA with a thermostable DNA polymerase. Science 230, 487–491 (1988).
    Article Google Scholar
  42. Prochownik, E.V. & Van Antwerp, M.E. Differential patterns of DNA binding by myc and max proteins. Proc. natn. Acad. Sci. U.S.A. 90, 960–964 (1993).
    Article CAS Google Scholar
  43. Epstein, I. in Prostate Biopsy Interpretation. Biopsy Interpretation Series. (ed. Silverberg, S.G ) 39–129 (Raven Press, New York, 1989).
    Google Scholar
  44. Sidransky, D. et al. Clonal expansion of p53 mutant cells in association with brain tumor progression. Nature 355, 646–847 (1992).
    Article Google Scholar
  45. Marshall, R. et al. Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myetogenous leukemia. Blood 75, 180–189 (1990).
    Google Scholar
  46. Nakai, H., Misawa, S., Toguchida, J., Yandell, D.W. & Ishizaki, K. Frequent p53 gene mutations in blast crisis of chronic myetogenous leukemia, especially In myetoid crisis harboring loss of chromsome 17p. Cancer Res. 52, 6588–6593 (1992).
    CAS PubMed Google Scholar
  47. Baker, S.J. et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50, 7717–7722 (1990).
    CAS Google Scholar
  48. Frankel, R.H., Bayona, W., Koslow, M. & Newcomb, E.W. p53 mutations in human malingnant glomas: comparison of loss of heterzygosity with mutation frequency. Cancer Res. 52, 1427–1433 (1992).
    CAS PubMed Google Scholar
  49. Brennan, T.J. & Olson, E.N. Myogenin resides In the nucleus and acquires high affinity for a conserved enhancer element on heterodemerizatton. Genes Dev. 4, 582–595 (1990).
    Article CAS Google Scholar
  50. Dang, C.V., Dolde, C., Gillison, M.L. & Kato, G.J. Discrimination between related DNA sites by a single amino acid residue of Myc-related basic helix-loop-helix protein. Proc. natn. Acad. Sci. U.S.A. 88, 599–601 (1992).
    Article Google Scholar
  51. Van Antwerp, M.E., Chen, D.G., Chang, C. & Prochownik, E.V. A point mutation in the MyoD basic domain imparts c-myc-like properties. Proc. natn. Acad. Sci. U.S.A. 88, 9010–9014 (1992).
    Article Google Scholar
  52. Kunket, T.A. Rapid and efficient site-specific mutagenesis without phenotypic selections. Proc. natn. Acad. Sci. U.S.A. 82, 488–492 (1985).
    Article Google Scholar
  53. Jones, E., Zhu, X.L., Rohr, L.R., Stephenson, R.A. & Brothman, A.R. Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chrom. Cancer. 11, 163–170 (1994).
    Article CAS Google Scholar
  54. Zervos, A., Gyuris, J. & Brent, R., Errata. Cell. 79, 389 (1994).
    Article Google Scholar

Download references